Related Experiment Video
Updated: Apr 5, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Expression of poly(C)-binding protein 1 (PCBP1) in NSCLC as a negative regulator of EMT and its clinical value
Yifei Liu1, Ling Gai2, Jian Liu2
1Department of Pathology, Affiliated Hospital of Nantong University Nantong 226001, Jiangsu, China.
Abstract:
Poly (C)-binding Protein 1 (PCBP1) is a 35 kDa protein involved in a number of biological processes. Recently, the research found that PCBP1 might be involved in epithelial-mesenchymal transition (EMT). However, the role of PCBP1 in non-small-cell lung cancer (NSCLC) metastasis needs further elucidation. The purpose of this study was to determine whether PCBP1 could serve as a biomarker for stratification and prediction of prognosis in NSCLC as a regulator of EMT formation. In this study, PCBP1 expression was evaluated by Western blot in 8 fresh lung cancer tissues and immunohistochemistry (IHC) on 145 paraffin-embedded slices. PCBP1 was highly expressed in non-metastatic NSCLC specimens and significantly correlated with lymph node status (P < 0.001), clinical stage (P = 0.001), vimentin expression (P = 0.033) and E-cadherin expression (P = 0.042). Our study showed that the low expression of PCBP1 was correlated with decreased expression of E-cadherin and elevated expression of vimentin, which were the markers of EMT. Besides, high expression of PCBP1 was correlated with better prognosis. These findings suggested that PCBP1 might play an important role in preventing the process of EMT in NSCLC, thus be a promising therapeutic target to inhibit NSCLC metastasis.
Insights
Poly (C)-binding Protein 1 (PCBP1) may prevent non-small-cell lung cancer (NSCLC) metastasis by inhibiting epithelial-mesenchymal transition (EMT). High PCBP1 expression correlates with better prognosis, suggesting its potential as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Poly (C)-binding Protein 1 (PCBP1) is implicated in various biological processes.
- Emerging evidence suggests PCBP1's involvement in epithelial-mesenchymal transition (EMT).
- The specific role of PCBP1 in non-small-cell lung cancer (NSCLC) metastasis requires further investigation.
Purpose of the Study:
- To investigate PCBP1's role in NSCLC metastasis.
- To determine if PCBP1 can serve as a biomarker for NSCLC patient stratification and prognosis.
- To evaluate PCBP1's function as a regulator of EMT in NSCLC.
Main Methods:
- PCBP1 expression analysis using Western blot on fresh lung cancer tissues.
- Immunohistochemistry (IHC) evaluation of PCBP1 expression in 145 paraffin-embedded NSCLC specimens.
- Correlation analysis between PCBP1 expression and clinicopathological features, including lymph node status, clinical stage, vimentin, and E-cadherin expression.
Main Results:
- PCBP1 was highly expressed in non-metastatic NSCLC tissues.
- High PCBP1 expression significantly correlated with favorable lymph node status and clinical stage.
- Low PCBP1 expression was associated with decreased E-cadherin and increased vimentin, key markers of EMT.
Conclusions:
- PCBP1 expression levels are linked to NSCLC progression and patient outcomes.
- PCBP1 appears to inhibit EMT, thereby suppressing NSCLC metastasis.
- PCBP1 represents a potential therapeutic target for mitigating NSCLC metastasis.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Master Transcription Regulators
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Cell Specific Gene Expression

